ArticleFrontiers in pharmacology2022

Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study.

Wen-Hsuan Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.